Your Health, We Care
Tirzepatide is indicated as an adjunct to diet and exercise to improve glycemic control in adult and pediatric patients with type 2 diabetes mellitus aged 10 years and older. It is the first and currently the only GIP and GLP‑1 receptor agonist proven to improve glycemic control in adults with type 2 diabetes.
Who should not use Tirzepatide?Tirzepatide is contraindicated in patients who are allergic to tirzepatide or any of its excipients (excipients include disodium hydrogen phosphate h···【more】
Article source：Lucius LaosRelease date：2026-05-15Recommended：15
What is Tirzepatide?Tirzepatide contains the active substance tirzepatide. It is a clear, colourless to light yellow solution for subcutaneous injection. There are six strengths: 2···【more】
Article source：Lucius LaosRelease date：2026-05-15Recommended：13
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
